Post-earnings recap
Reported
Tue, Feb 20, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
The earnings report indicates that Medtronic faced challenges this quarter, particularly reflected in the EPS miss. However, the stock rose by 1.69%, suggesting that investors may be optimistic about the company's long-term strategy and ongoing investments in innovation despite the short-term setback.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.99 | N/A | -21.55% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a cautious optimism regarding future performance despite missing EPS expectations. They emphasized their commitment to innovation and market expansion.
Management acknowledged the challenges faced during the quarter but expressed confidence in long-term growth.
They highlighted ongoing investments in innovation as a key focus moving forward.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—